Avoro Capital Advisors LLC
Source: SEC Form 13F · as of Mar 2026Avoro Capital Advisors LLC holds 17 biotech & pharma companies tracked by BioSniper, totaling $3.97B in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$3.97B
BioSniper AIPage context preserved
Prepared research question
What matters most for ARGENX SE (ARGX)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| ARGXARGENX SE | 1,000,000 | $730.3M |
| ARWRARROWHEAD PHARMACEUTICALS, INC. | 10,699,999 | $670.9M |
| APLSApellis Pharmaceuticals, Inc. | 12,222,222 | $491.7M |
| CNTACentessa Pharmaceuticals plc | 11,430,455 | $454.0M |
| GPCRStructure Therapeutics Inc. | 6,555,555 | $316.0M |
| TERNTerns Pharmaceuticals, Inc. | 5,695,000 | $300.2M |
| RVMDREVOLUTION MEDICINES, INC. | 2,344,444 | $228.0M |
| CYTKCYTOKINETICS INC | 3,333,333 | $219.7M |
| OCULOCULAR THERAPEUTIX, INC | 12,315,000 | $104.3M |
| DMRADamora Therapeutics, Inc. | 3,783,000 | $98.0M |
| QUREuniQure N.V. | 5,959,595 | $97.4M |
| DFTXDefinium Therapeutics Inc. | 5,000,000 | $94.5M |
| SLNOSOLENO THERAPEUTICS INC | 2,300,000 | $77.0M |
| VRDNViridian Therapeutics, Inc.\DE | 1,500,000 | $29.3M |
| GHRSGH Research PLC | 1,800,000 | $25.3M |
| AVTXAvalo Therapeutics, Inc. | 1,410,000 | $21.1M |
| WHWKWhitehawk Therapeutics, Inc. | 2,849,402 | $9.8M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.